Pharmaceutical kit for migraine headache treatment

Abstract

A pharmaceutical kit for treating migraine headaches and method of preparing the kit that includes a therapeutically effective dosage of pharmaceutical compounds used in the treatment of migraine headache. The pharmaceutical kit is manufactured with a predetermined number of dosage units of migraine treating pharmaceutical compounds. Additionally the kit provides all components necessary for the administering of the drugs in a safe and convenient manner. An aspect of the pharmaceutical kit may include injections and nasal sprays that are fast acting for relief of the migraine sufferer. A preferred pharmaceutical kit with only oral dosage units of drugs may be provided as an attachment to a water bottle.

1 . A pharmaceutical kit, comprising: 
 a) a container including a therapeutically effective dosage of a plurality of pharmaceutical compounds useful for treating a medical condition.    b) a vessel containing a liquid and packaged with said container for use in facilitating the oral administering of the pharmaceutical compounds; and    c) printed instructions setting forth the safe and effective use of the contents of pharmaceutical kit.    
   
   
       2 . The pharmaceutical kit as recited in  claim 1 , wherein said medical condition is selected from the group consisting of anxiety, palpitations, high blood pressure, nausea, mood swings and migraine headaches.  
   
   
       3 . The pharmaceutical kit as recited in  claim 2 , wherein said medical condition is a migraine headache.  
   
   
       4 . A pharmaceutical kit, comprising: 
 a) a container including a therapeutically effective dosage of a plurality of pharmaceutical compounds for treating migraine headaches;    b) a vessel of water packaged with said container, said vessel of water having an upper portion and a lower portion, and being used for administering of the compounds which are to be orally administered; and    c) printed instructions setting forth the safe and effective use of the contents pharmaceutical kit for treating a migraine headache.    
   
   
       5 . The pharmaceutical kit as recited in  claim 4 , wherein said plurality of pharmaceutical compounds comprises at least one of each of a serotonin elevating compound, a dopamine blocking compound, and a prostaglandin inhibiting compound.  
   
   
       6 . The pharmaceutical kit as recited in  claim 5 , wherein said serotonin elevating compound is a triptan compound.  
   
   
       7 . The pharmaceutical kit as recited in  claim 6 , wherein said triptan compound is selected from the group consisting of sumatriptan, rizatriptan, zolmatriptan and almotriptan.  
   
   
       8 . The pharmaceutical kit as recited in  claim 4 , wherein said dopamine blocking compound is selected from the group consisting of chlorpropamide, metaclopramide and prochlorperazine.  
   
   
       9 . The pharmaceutical kit as recited in  claim 4 , wherein said prostaglandin inhibiting compound is selected from the group consisting of acetyl salicylic acid, acetaminophen, ibuprofen and naproxen.  
   
   
       10 . The pharmaceutical kit as recited in  claim 5 , wherein said serotonin elevating compound comprises at least two 100 mg dosage units of sumatriptan for oral administration and two 50 mg dosage units of sumatriptan for oral administration.  
   
   
       11 . The pharmaceutical kit as recited in  claim 5 , wherein said dopamine blocking compound comprises at least two 10 mg dosage units of metaclopramide HCl for oral administration.  
   
   
       12 . The pharmaceutical kit as recited in  claim 5 , wherein said prostaglandin inhibiting compound comprises at least two 800 mg dosage units of ibuprofen for oral administration.  
   
   
       13 . The pharmaceutical kit as recited in  claim 5 , wherein said prostaglandin inhibiting compound comprises at least two 500 mg dosage units of naproxen for oral administration.  
   
   
       14 . The pharmaceutical kit as recited in  claim 4 , further comprising at least one injection device containing a therapeutically effective dosage of sumatriptan, said injection device being included in said container for injection of said sumatriptan below the skin of a user.  
   
   
       15 . The pharmaceutical kit a recited in  claim 14 , further comprising an alcohol swab packet included in said container, said alcohol swab packet for application on and preparation of the user's skin associated with the injection of the sumatriptan.  
   
   
       16 . The pharmaceutical as recited in  claim 4 , further comprising at least one nasal spray device having a therapeutically effective dosage of sumatriptan, said nasal spray device for administering said sumatriptan through the nasal passages of a user.  
   
   
       17 . The pharmaceutical kit as recited in  claim 4 , wherein the vessel of water packaged with said container is attached to the container to provide a convenient, self contained migraine headache treatment kit.  
   
   
       18 . The pharmaceutical kit as recited in  claim 17 , wherein said vessel is of a cylindrical shape and has an outer side wall and an inner side wall, said vessel further having threading on the lower portion of the vessel of water which is complementary with threading on the inner side wall so as to couple the container to the vessel.  
   
   
       19 . The pharmaceutical kit as recited in  claim 18 , wherein the vessel of water attached to the container comprises an integrally manufactured unitary member having a revolving cover with a cutout window hinge pin for providing access to the pharmaceutical kit contents.  
   
   
       20 . A pharmaceutical vessel, comprising: 
 a. a container having a top end and a bottom end;    b. cylindrical walls defining said vessel and extending from the top to the bottom;    c. a detachable housing connected to said container at the bottom end; and    d. said housing having one or more compartments for containing one or more pharmaceutical compounds.    
   
   
       21 . The pharmaceutical vessel as recited in  claim 20 , wherein said bottom end of said vessel is provided with screwable threading  
   
   
       22 . The pharmaceutical vessel as recited in  claim 20 , wherein said housing has an upper end and a lower end, said upper end is provided with screwable threading on an interior surface  
   
   
       23 . The pharmaceutical vessel as recited in  claim 22 , wherein said threading on said interior surface of said housing is complementary with said threading on said bottom end of said vessel.  
   
   
       24 . The pharmaceutical vessel as recited in  claim 20 , wherein said housing is detachably connected to said vessel.  
   
   
       25 . The pharmaceutical vessel as recited in  claim 20 , wherein said housing is further provided with a revolving cover cutout window and a hinge pin for providing access to the pharmaceutical compounds contained in the compartments therein.  
   
   
       25 . A pharmaceutical vessel, comprising: 
 a. a container having a top end and a bottom end;    b. cylindrical walls defining said vessel and extending from said top end to said bottom end;    c. one or more compartments positioned within said bottom end of said container for holding one or more pharmaceutical compounds.